Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) per Common Share - Schedule of Securities Excluded (Details)

v3.22.2
Earnings (Loss) per Common Share - Schedule of Securities Excluded (Details) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Potential antidilutive shares 26,227,601 36,561,492 26,112,102 36,561,492
Convertible notes payable        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Potential antidilutive shares 0 8,695,652 0 8,695,652
Outstanding warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Potential antidilutive shares 24,365,719 24,365,719 24,365,719 24,365,719
Stock options        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Potential antidilutive shares 946,560 3,500,121 946,560 3,500,121
Restricted stock units        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Potential antidilutive shares 915,322 0 799,823 0